bibliographicCitation |
Kunimitsu Y, Morio K, Hirata S, Yamamoto K, Omura T, Hara T, Harada K, Fujisawa M, Yano I. Effects of Proton Pump Inhibitors on Survival Outcomes in Patients with Metastatic or Unresectable Urothelial Carcinoma Treated with Pembrolizumab. Biological & Pharmaceutical Bulletin. 2022 May 01;45(5):590–5. doi: 10.1248/bpb.b21-00939. |